Though it is still in development, a blood test may be able to detect pancreatic cancer in early stages, according to a proof of concept study published in Cancer Prevention Research.
Probiotics don’t stop superbugs from colonizing in very ill patients’ intestinal tracts, according to a recent study published in the journal Infection Control and Hospital Epidemiology.
Genetic mutations in hereditary colorectal cancers may be detectable, according to findings published in the Journal of Molecular Diagnostics.
Age and toll-like receptor 4 (TLR4) play a part in how the lungs respond to ozone, according to a recent study by Kelsa Gabehart, PhD, of the Department of Pediatrics, National Jewish Health, in Denver, Colorado, and colleagues.
Psoriasis patients are susceptible to artery inflammation, increasing their risk for cardiovascular disease.
Having HIV puts patients co-infected with hepatitis C at far higher risk. A Baltimore team looked at using statins to slow the course of the liver disease.
Using "big data" a research team from the University of Chicago and other institutions found that where infectious disease training programs are more common, patients with HIV/AIDS do better.
Percutaneous liver biopsy is a proven way to rate the fibrosis stage both in hepatitis in chronic hepatitis C patients and hepatitis B patients. But it is uncomfortable for patients, risks complications and is prone to assembling errors.
Reporting at ID Week 2015 in San Diego, CA, Tuma Demirdal, DR, and colleagues at the Katip Celebi University in Izmir, Turkey compared these invasive tests with non-invasive methods.